Your browser doesn't support javascript.
loading
Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Liu, Dandan; Lv, Hang; Liu, Qi; Sun, Yanli; Hou, Shenglong; Zhang, Lu; Yang, Mengyue; Han, Baihe; Wang, Gang; Wang, Xuedong; Du, Wenjuan; Nie, Honggang; Zhang, Ruoxi; Huang, Xingtao; Hou, Jingbo; Yu, Bo.
Afiliación
  • Liu D; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Lv H; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Liu Q; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Sun Y; Division of Cardiovascular Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Hou S; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Zhang L; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Yang M; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Han B; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Wang G; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Wang X; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Du W; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Nie H; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Zhang R; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Huang X; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
  • Hou J; Division Department of Cardiology Organization, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Yu B; Key Laboratories of the Education Ministry for Myocardial Ischemia Mechanisms and Treatment, Harbin, China.
J Transl Med ; 17(1): 378, 2019 11 15.
Article en En | MEDLINE | ID: mdl-31730006
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Transcripción / Transactivadores / Metotrexato / Hemorreología / Proteínas Adaptadoras Transductoras de Señales / Aterosclerosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Transl Med Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Factores de Transcripción / Transactivadores / Metotrexato / Hemorreología / Proteínas Adaptadoras Transductoras de Señales / Aterosclerosis Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Transl Med Año: 2019 Tipo del documento: Article País de afiliación: China